Parker Waichman LLP

Manipulated Data to Gain FDA Approval of Zolgensma

Novartis Pharmaceuticals Used Manipulated Data to Gain FDA Approval of Gene Therapy Drug Novartis Pharmaceuticals, a global drug company, recently revealed that the company submitted an application to the United States Food and Drug Administration (FDA) for approval of Zolgensma, a gene therapy drug, with manipulated data.  The FDA is aggressively investigating the situation but […]

Novartis Pharmaceuticals Used Manipulated Data to Gain FDA Approval of Gene Therapy Drug

Novartis Pharmaceuticals Used Manipulated Data to Gain FDA Approval of Gene Therapy Drug Zolgensma

Manipulated data of Zolgensma

Novartis Pharmaceuticals, a global drug company, recently revealed that the company submitted an application to the United States Food and Drug Administration (FDA) for approval of Zolgensma, a gene therapy drug, with manipulated data.  The FDA is aggressively investigating the situation but claims Zolgensma is still safe to be on the market.  Novartis has a history of committing acts that are potentially illegal and wrongful, conduct which poses a risk of harm to patients.

What is Zolgensma?

Zolgensma is a gene therapy drug carrying a price tag of $2.1 million for one dose – the most expensive drug on the planet.  Zolgensma is used to treat children under the age of 2 who have been diagnosed with spinal muscular atrophy (SMA), a rare genetic disorder involving mutations of a gene that is necessary for proper muscle control and movement.  To be diagnosed with SMA, a child must inherit mutated genes from both parents.

Novartis’ Application for Approval of Zolgensma

Novartis submitted its application for FDA approval of Zolgensma in early 2019.  As of March 14, 2019, AveXis, a subdivision of Novartis dedicated to gene therapy, was aware of the data manipulation.  Zolgensma gained FDA approval on May 24, 2019, and according to the FDA, Novartis “did not inform FDA of the issue until over a month” after Zolgensma was approved. As such, Novartis, or at least its subdivision, AveXis, knew about the manipulated data two months before Zolgensma hit the market.  AveXis was acquired by Novartis last year after the company decided to enter the gene therapy industry.

The approval of Zolgensma would likely have been delayed had the FDA been informed about the manipulated data before May 24, 2019.  It is unclear whether any person beyond those working within AveXis knew about the data manipulation.  However, Novartis is still responsible for the conduct of its subsidiaries.

FDA Investigation Under Way – Novartis May Face Potential Civil and Criminal Penalties

The FDA is investigating to determine how and why Novartis submitted a drug application with manipulated data.  While the FDA asserts that the manipulated data pertains to animal, and not human, studies, and such data has no effect on the current use of Zolgensma, submitting a drug application with manipulated data is concerning, and a punishable act. The FDA indicates that “civil or criminal penalties” may be warranted pending results of the agency’s investigation.

Novartis Has a History of Data Manipulation and Criminal Conduct

Manipulating data on a drug application is not the only unlawful act Novartis has been linked to. Between 2013 and 2015, Novartis allegedly manipulated data and failed to report side effects for some of its drugs in Japan, prompting numerous scandals as Japanese authorities discovered the unlawful conduct.

Additionally, Novartis has faced bribery allegations in recent years in other countries, painting the drug company as corrupt.  Moreover, just last year, Novartis was linked to Michael Cohen, President Trump’s former personal attorney, when it was revealed in congressional testimony that the drug company paid Michael Cohen 1.2 million to act as a consultant on matters about President Trump.  Michael Cohen allegedly met with representatives from Novartis on 6 occasions, information that was never supposed to become public knowledge.

While the new CEO of Novartis has pledged to clean up the drug company’s act, the recent discovery that the company submitted a drug application to the FDA with manipulated data only furthers the company’s reputation as unlawful and corrupt.


What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Parker Waichman LLP helped me with my case. It all started with a visit from Jorge Peniche who was extremely professional, courteous and detailed with my case. All of my questions and concerns were addressed. I was provided with evidence, my emails, phone calls and inquiries were addressed in a timely fashion with great guidance and care. I am very grateful and appreciative as I had never been through this experience. They were great, a special thanks to Jorge Peniche, who was amazing, the lawyer in my case, Denny Tang and the nurse at the firm. Greatly appreciated. Kindly, Kathy
Kathy M
4 years ago
5 Star Reviews 150
Positive: Professionalism , Quality , Responsiveness , Value Parker Waichman took care of everything related to my claim. My questions and calls were responded to quickly. My claim was resolved as expected. A+++
Kenneth Kohlmier
3 years ago
5 Star Reviews 150
I like to thank Joanne and the team at Parker and waichman for their caring about my health due to my unfortunate back pain I have been suffering with the team reach out to me weekly to keep me updated on the process I would recommend them to family and friends.thank you guys for all the support truly appreciate you.
Sharon Sharp
5 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038